Searched for
CHRYSCAPITAL NEWS
Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
SaaS startup MoEngage closes extended $280 million round; ChrysCapital, Dragon Fund, Schroders joinMoEngage has secured an additional $180 million in funding, elevating its total investment haul to $280 million. With a current valuation o...
Foxconn may set up EV factory in India this year; ChrysCapital invests $100 million in LenskartEnding the week with a bang (and not a whimper) is this big piece of news: iPhone maker Foxconn is in talks with some Indian states to set ...
Lenskart bags $100 million from ChrysCapital; CCI challenges parts of NCLAT order on GoogleAfter having secured $500 million from Abu Dhabi Investment Authority (ADIA), the Gulf Sovereign wealth fund (SWF) in March, eyewear startu...
Canada's pension fund giant Ontario Teachers opens India officeA founding team of approximately 10 team members will be based in Ontario Teachers’ Mumbai office by the end of 2022, comprising a mix of l...
Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
ChrysCapital set to launch $1.2 billion PE fundChrys Capital IX would be the largest by an India-specific fund manager
ChrysCap-backed Infogain begins talks to offload controlling stakeThe Infogain stake sale process includes the issue of new shares and the sale of stake by some existing investors, including ChrysCapital, ...
ETtech Exclusive: FirstCry to launch $75-million Thrasio-style investment ventureThe country's largest venture will have capital committed by SoftBank , TPG and Premji Invest
Patni family backed, PlexusMD join hands with Eris Lifesciences for SaarthiSaarthi, the AI-powered learning platform endeavours to enable Indian physicians to stay connected with global developments and practice ev...
ChrysCapital set to acquire 10% in Mankind for $350 millionInvestment bank Moelis & Co has been running a keenly contested formal process that had also seen interest from Warburg Pincus, General Atl...
Carlyle Group leads race for 15 per cent in Mankind PharmaceuticalsThe company, which is the maker of leading brands such as Manforce condoms, PregaNews and Unwanted 72, has presence in about 22 countries a...
Apax Partners, Carlyle front-runners for Mankind Pharma stake saleApax Partners & Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two s...
Mankind Pharma looking to sell 15 per cent stake; PE funds make a bee-lineMankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.
ChrysCapital exits Mankind, sells 11% stake to Capital International for $200 millionMankind has been growing at a compounded annual growth rate of 20% for the last five years, with revenues touching Rs 3,500 crore in year e...
Warburg Pincus offers $250 million for 11 per cent stake in rival ChrysCapital’s Mankind PharmaChrysCapital, which purchased the stake in 2007 for $24 mn will earn a 9-fold return, striking one of the largest exits in pharma sector by...
ChrysCapital in talks with private equity firms to sell 11% in Mankind Pharma$200 million for its 11% holding, which if realized, with fetch a return of more than 8 times on the seven-year-old investment.
ChrysCapital to sell 10% in drug maker Intas Pharmaceuticals to Temasek for over $160 millionTemasek has bought 12.5% stake in Intas Pharmaceuticals, one of India's top 10 drug makers by sale, for a little over Rs 1,100 crore, peopl...
- Many deals didn’t meet our investment criteria: Chrys Capital
In conversation with ET , Mr Kaul, managing director, ChrysCapital discusses the changing landscape of Indian pharma and the firm’s investm...
- Stocks to watch on Wednesday
Equities are expected to see a positive opening Wednesday after global cues turned for the better as oil prices slid below $122.